In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company in the world.

Prothena Corporation plc's stock has dropped 67% since my last “Buy” rating, primarily due to delays and a lack of meaningful ...

Fintel reports that on October 17, 2024, Bernstein initiated coverage of Eli Lilly and (NYSE:LLY) with a Outperform ...

The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value.

Companies usually only issue stock splits after extended periods of strong returns, and a stock split is a sign a company's ...

Eighty states, cities, counties, school boards and unions have joined litigation in a New Jersey district court against the three major pharmacy middlemen.

Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.

The company has committed £279 million ($364 million) to support national efforts aimed at reducing obesity, a critical ...

DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating yesterday. Nico Chen has given his Buy rating due ...

Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...

Health secretary Wes Streeting believes obesity is a factor negatively affecting the UK's economy and has put forward plans ...

Hims & Hers Health shares rose Monday after the Food and Drug Administration said compounding pharmacies could continue to ...